{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T03:01:22Z","timestamp":1648954882584},"reference-count":41,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1783,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1111\/j.1468-1293.2010.00886.x","type":"journal-article","created":{"date-parts":[[2010,10,15]],"date-time":"2010-10-15T02:06:27Z","timestamp":1287108387000},"page":"308-315","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of the possible influence of hepatitis C virus and liver fibrosis on HIV type 1 immunological and virological outcomes"],"prefix":"10.1111","volume":"12","author":[{"given":"J","family":"Collazos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JA","family":"Cart\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Asensi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,10,14]]},"reference":[{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4269\/ajtmh.2006.74.239","article-title":"Morbidity and mortality profile of human immunodeficiency virus-infected patients with and without hepatitis C co-infection","volume":"74","author":"Mayor","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00126334-200307010-00011","article-title":"The impact of hepatitis C virus coinfection on HIV progression before and after highly active antiretroviral therapy","volume":"33","author":"Klein","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1310\/YFV8-FE5K-5LN9-DQ4C","article-title":"Impact of chronic hepatitis C on HIV-1 disease progression","volume":"5","author":"Carlos Mart\u00edn","year":"2004","journal-title":"HIV Clin Trials"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB4|cit4","first-page":"1800","article-title":"Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection","volume":"356","author":"Greub","year":"2000","journal-title":"the Swiss HIV Cohort Study"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB5|cit5","first-page":"1481","article-title":"Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals","volume":"42","author":"Weis","year":"2006","journal-title":"a nationwide cohort study"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1001\/archinte.162.18.2125","article-title":"Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects","volume":"162","author":"De Luca","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1590\/S1413-86702008000300003","article-title":"The influence of HCV coinfection on clinical, immunological and virological responses to HAART in HIV-patients","volume":"12","author":"Carmo","year":"2008","journal-title":"Braz J Infect Dis"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1530-0277.2007.00381.x","article-title":"Impact of hepatitis C on HIV progression in adults with alcohol problems","volume":"31","author":"Cheng","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1086\/430445","article-title":"Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals","volume":"40","author":"Antonucci","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10096-007-0384-3","article-title":"Impact of hepatitis C virus coinfection on immune restoration during successful antiretroviral therapy in chronic human immunodeficiency virus type 1 disease","volume":"27","author":"Santin","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB11|cit11","first-page":"82","article-title":"Hepatitis C virus (HCV) coinfection in a cohort of HIV positive long-term non-progressors","volume":"39","author":"Morsica","year":"2007","journal-title":"possible protective effect of infecting HCV genotype on HIV disease progression"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1086\/498908","article-title":"Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV\/AIDS treatment program","volume":"193","author":"Braitstein","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB13|cit13","first-page":"713","article-title":"Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy","volume":"41","author":"Miller","year":"2005","journal-title":"a meta-analysis"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10096-003-1015-2","article-title":"Impaired recovery of CD4+cell counts following highly active antiretroviral therapy in drug-na\u00efve patients coinfected with human immunodeficiency virus and hepatitis C virus","volume":"22","author":"Mac\u00edas","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1468-1293.2003.00152.x","article-title":"HIV\/HBV and HIV\/HCV coinfection, and outcomes following highly active antiretroviral therapy","volume":"4","author":"Lincoln","year":"2003","journal-title":"HIV Med"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB16|cit16","first-page":"613","article-title":"Effects of hepatitis C virus coinfection on survival in veterans with HIV treated with highly active antiretroviral therapy","volume":"39","author":"Backus","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1086\/318539","article-title":"Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs","volume":"183","author":"Daar","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1086\/432885","article-title":"Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+cell count but does increase the likelihood of AIDS-defining events","volume":"41","author":"Stebbing","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB19|cit19","first-page":"1507","article-title":"Hepatitis C virus coinfection increases mortality in HIV-infected patients in the highly active antiretroviral therapy era","volume":"39","author":"Anderson","year":"2004","journal-title":"data from the HIV Atlanta VA Cohort Study"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2893.2000.00227.x","article-title":"Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients","volume":"7","author":"Piroth","year":"2000","journal-title":"J Viral Hepat"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00002030-199804000-00006","article-title":"Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?","volume":"12","author":"Piroth","year":"1998","journal-title":"AIDS"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/QAI.0b013e318198a0e1","article-title":"Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression","volume":"50","author":"Peters","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB23|cit23","first-page":"1202","article-title":"Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV\/HIV-coinfected women","volume":"193","author":"Al-Harthi","year":"2006","journal-title":"role of HCV on expression of primed\/memory T cells"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1089\/aid.2008.0069","article-title":"Hepatitis C virus coinfection does not affect CD4 restoration in HIV-infected patients after initiation of antiretroviral therapy","volume":"24","author":"Yacisin","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB25|cit25","first-page":"387","article-title":"Epidemiological, immunological and virological characteristics, and disease progression of HIV-1\/HCV-co-infected patients from a southern Brazilian population","volume":"21","author":"Reiche","year":"2008","journal-title":"Int J Mol Med"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/00002030-200405210-00010","article-title":"Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort","volume":"18","author":"Law","year":"2004","journal-title":"AIDS"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/00002030-200209270-00008","article-title":"Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects","volume":"16","author":"Chung","year":"2002","journal-title":"AIDS"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.288.2.199","article-title":"Hepatitis C and progression of HIV disease","volume":"288","author":"Sulkowski","year":"2002","journal-title":"JAMA"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00042737-199806000-00009","article-title":"The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users","volume":"10","author":"Haydon","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/infdis\/172.6.1503","article-title":"Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study","volume":"172","author":"Dorrucci","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/432762","article-title":"Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy","volume":"192","author":"Rockstroh","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/01.aids.0000226958.87471.48","article-title":"Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy","volume":"20","author":"Sullivan","year":"2006","journal-title":"AIDS"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB33|cit33","first-page":"859","article-title":"Hepatitis C virus coinfection and HIV load, CD4+cell percentage, and clinical progression to AIDS or death among HIV-infected women","volume":"40","author":"Hershow","year":"2005","journal-title":"Women and Infants Transmission Study"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1198-743X.2005.01347.x","article-title":"Influence of hepatitis C and hepatitis G virus co-infection on viral and cellular dynamics in patients infected with human immunodeficiency virus following interruption of highly active anti-retroviral therapy","volume":"12","author":"Soriano-Sarabia","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1089\/aid.2006.0251","article-title":"Clinicoimmunological progression and response to treatment of long-term nonprogressor HIV-hepatitis C virus-coinfected patients","volume":"23","author":"Castro","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1086\/345953","article-title":"Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy","volume":"36","author":"Tedaldi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/00002030-200207050-00007","article-title":"Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?","volume":"16","author":"Rancinan","year":"2002","journal-title":"AIDS"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MAJ.0b013e31811ec780","article-title":"Liver enzymes elevation and immune reconstitution among treatment-na\u00efve HIV-infected patients instituting antiretroviral therapy","volume":"334","author":"Ofotokun","year":"2007","journal-title":"Am J Med Sci"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1042\/CS20080532","article-title":"Effects of HCV co-infection on apoptosis of CD4+T-cells in HIV-positive patients","volume":"116","author":"K\u00f6rner","year":"2009","journal-title":"Clin Sci (London)"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1086\/508355","article-title":"Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients","volume":"43","author":"N\u00fa\u00f1ez","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1468-1293.2010.00886.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1097\/00002030-200411190-00013","article-title":"Infection with concurrent multiple hepatitis C virus genotypes is associated with faster HIV disease progression","volume":"18","author":"van Asten","year":"2004","journal-title":"AIDS"}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2010.00886.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1468-1293.2010.00886.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T21:23:43Z","timestamp":1625520223000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2010.00886.x"}},"subtitle":["HCV, fibrosis and viroimmunological outcomes"],"short-title":[],"issued":{"date-parts":[[2010,10,14]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2010.00886.x","relation":{},"ISSN":["1464-2662"],"issn-type":[{"value":"1464-2662","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10,14]]}}}